Business Wire

The Pink Ribbon Turns 25: The Estée Lauder Companies’ Breast Cancer Campaign Reaches 25 Year Milestone

Jaa

The Estée Lauder Companies honors the 25th Anniversary of The Breast Cancer Campaign (formerly known as The Breast Cancer Awareness Campaign) and the co-creation of the iconic pink ribbon by its visionary founder, the late Evelyn H. Lauder.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170928005489/en/

The 2017 Estée Lauder Companies' Breast Cancer Campaign ad visual (Graphic: Business Wire)

The 2017 Estée Lauder Companies' Breast Cancer Campaign ad visual (Graphic: Business Wire)

25 years ago there was no pink ribbon. Women around the world were dying from breast cancer and there was very little discussion about it. Mrs. Lauder saw an urgent need to bring breast cancer to the forefront and put a spotlight on this world health issue. In 1992, she became a pioneer for the breast cancer movement, co-creating the pink ribbon and launching The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign). A year later, she founded the Breast Cancer Research Foundation® (BCRF), a non-profit organization, to generate funding solely dedicated to breast cancer research. Today, the pink ribbon is the ubiquitous symbol of breast health and The Campaign is a global leading voice for breast cancer, igniting a worldwide movement that has funded innovative research and awareness, and inspired meaningful action.

To mark the 25th Anniversary, The Estée Lauder Companies has a new mission: to create a breast cancer-free world. A bold, thought-provoking visual of a tattered pink ribbon is being introduced, showing the wear and tear of 25 years of hard work, dedication and impact trying to cure this disease. It also represents the hope that in 25 years, there will be no need for a pink ribbon; breast cancer will be committed to the history books. The Campaign no longer carries the word “Awareness” as breast cancer now has the global spotlight it deserves, moving into the future with a new rally – it’s time to end breast cancer.

The Campaign is now active in more than 70 countries around the world, partnering with more than 60 regional organizations to address areas of most critical need. The Campaign has raised more than $70 million to support global research, education and medical services, funding 225 medical research grants through BCRF ($56 million from total funds raised). To date:

  • Breast cancer mortality rates have decreased by 38% since the late 1980s.1
  • Five-year survival rates are better than 90% when breast cancer is found early2
  • Treatments are being customized to a person’s type of breast cancer, as breast cancer was revealed to be not one disease, but several different types
  • Surgery is not as invasive, and most women can have a lumpectomy and not a full breast removal (mastectomy)

William P. Lauder, Executive Chairman of The Estée Lauder Companies Inc., continues to honor the legacy of his late mother and proudly champions The Campaign’s work worldwide stating, “Supporting the development of critical research, driving awareness, and helping to eliminate the cultural barriers that can prevent the identification and treatment of breast cancer has been our core Company focus since my mother Evelyn H. Lauder founded The Breast Cancer Campaign 25 years ago. I am continuously humbled and energized by the passion and care exhibited by our employees and the tireless dedication of our partners—whose work is getting us closer to a global cure each and every day. As a Company, our commitment has not and will not waver.”

The Campaign unites partners and influencers worldwide, demonstrating the power of taking action together and inspiring others to make a difference. “Throughout my travels as Global Ambassador for The Estée Lauder Companies’ Breast Cancer Campaign, I’ve seen the hope that advancing breast cancer research is bringing,” said Elizabeth Hurley, Global Ambassador for The Breast Cancer Campaign. “I’ve seen first-hand the strength of those fighting breast cancer and the strength of friends and family who are supporting them in their fight, and I truly believe that together we can help turn the corner and bring breast cancer to an end.”

The Estée Lauder Companies is launching global efforts to support The Campaign:

  • Largest-ever one-year commitment of $8 million in financial contributions
  • A social fundraising effort, in which The Estée Lauder Companies will donate $25 to fund a half-hour of breast cancer research through BCRF for every unique post on Instagram or Twitter with both #PinkRibbon25 and #ELCdonates between September 15, 2017 and October 31, 2017, with the goal of funding a maximum of 500 research hours
  • Illumination of buildings, monuments and landmarks worldwide in glowing pink lights to raise awareness of breast health – including the Empire State Building, New York City and the Eiffel Tower, Paris
  • Release of a documentary short film, “Unraveling the Pink Ribbon: Creating a Breast Cancer-Free World,” directed by Sophy Holland, honoring Mrs. Lauder and highlighting progress made
  • Distribution of informational brochures and pink ribbons at The Estée Lauder Companies’ beauty brand counters worldwide

“The Estée Lauder Companies has long been committed to making an impact on communities around the world, and our efforts through The Breast Cancer Campaign are a reflection of that purpose,” said Fabrizio Freda, President and Chief Executive Officer, The Estée Lauder Companies Inc. “The awareness we’ve brought to the movement brings us great pride, and fuels the next – and what we hope to be the last - stage of The Campaign: ending breast cancer.”

The following brands of The Estée Lauder Companies will support The Campaign's mission: Aveda, Bobbi Brown, Bumble and bumble, Clinique, Darphin, DKNY, Donna Karan, Estée Lauder, Jo Malone London, La Mer, Lab Series, Origins, Prescriptives, Smashbox, Tom Ford Beauty and Tory Burch. Each will contribute by selling Pink Ribbon Products or making donations to BCRF and/or other charitable organizations around the world. This assortment differs by country and organization.

To support the 25th Anniversary of The Estée Lauder Companies’ Breast Cancer Campaign, visit bcacampaign.com, follow on social media @bcacampaign and use #PinkRibbon25.

ABOUT THE ESTÉE LAUDER COMPANIES INC.

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in over 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, M·A·C, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA and Too Faced.

1. Source: American Cancer Society Cancer Facts and Figures 2017 (https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html)

2. Source: American Cancer Society Understanding Breast Cancer Survival Rates (https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html)

Contact information

The Estée Lauder Companies
Bari Seiden-Young, 212-572-4475
bseiden@estee.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

A Better Way to Earn Interest on Digital Assets18.1.2019 04:00Tiedote

Cred, the leading provider of crypto borrowing and lending with over $300 million in credit facilities, today announced the launch of CredEarn* on the Uphold platform. CredEarn allows Uphold customers to lend their crypto and fiat assets to Cred and receive up to 10% of annualized interest. “We’re thrilled to offer consumers the opportunity to earn interest on their digital assets and fiat currencies,” said Dan Schatt, Co-founder and President of Cred. “In a bear market, customers can benefit from the liquidity they receive when obtaining a fixed amount of interest in USD or Stablecoin. In a bull market, customers also benefit by receiving the full upside on the amount of crypto they originally committed.” CredEarn customers can commit to a six-month term with the ability to rollover assets for additional periods. No account minimum is needed and interest is paid out in U.S. Dollars or Stablecoin every three months on Uphold. The principal is paid back in the fiat or crypto amounts tha

Servier and Taiho Oncology Present Latest LONSURF® (trifluridine/tipiracil) Data at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)18.1.2019 02:45Tiedote

Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today that the safety and efficacy data in the gastrectomy patient subgroup of the global Phase III trial TAGS evaluating LONSURF® (trifluridine/tipiracil, TAS-102) in patients with metastatic gastric cancer (mGC) are consistent with the overall study results published in The Lancet Oncology. These data were highlighted in an oral presentation at the ASCO 2019 Gastrointestinal Cancers Symposium (ASCO-GI) on Thursday 17 January. In TAGS, 221 (44%) of the 507 randomized mGC patients had undergone prior gastrectomy (147 LONSURF, 74 placebo), which is reflective of the real-world patient population diagnosed with mGC. The results confirmed that trifluridine/tipiracil prolonged survival versus placebo regardless of prior gastrectomy. The overall results of TAGS demonstrated that patients treated with oral trifluridine/tipiracil showed a clinically meaningful and statistically s

ISACA Announces 2019 Slate of Events for Business Technology Professionals Around the Globe During its 50th Anniversary Year17.1.2019 22:24Tiedote

ISACA, a global association serving technology audit, assurance, governance and cybersecurity professionals, celebrating its 50th anniversary in 2019, announced its annual event schedule, which includes learning opportunities focused on emerging technologies, innovation, best practices and professional development. Disruptive technologies over the last 50 years and in the future of business enterprise, and the evolution of technology careers and ISACA professions, will be featured in conjunction with the ISACA anniversary year at nearly every venue. ISACA’s growing Cybersecurity Solution Portfolio, including the CSX Training Platform and the CMMI Cybermaturity Platform, will be highlighted in new conferences in 2019, which will include events in North America and Europe. The 2019 CACS conferences, set for North America, Europe, Asia, Africa, the Oceania region and Latin America, will offer educational sessions in audit and assurance, big data, risk management, governance and more. All

HighLife Closes a €32 Million Round B Financing17.1.2019 20:25Tiedote

HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which includes regulatory approval trials in Europe to obtain the CE mark and a first clinical trial in the U.S. via an Early Feasibility Study (EFS). The Series B round was co-led by U.S. Venture Partners (“USVP”) and Andera Partners, with Sectoral Asset Management and Jose Calle Gordo, Chairman of the company, joining the round. Sofinnova Partners, which led the Series A round, continues to support the company and participated in this latest round of financing. Bryan Garnier & Co (Paris) acted as private placement agent for this financing. “I am very pleased to announce the closing of the Ser

The Brightline™ Initiative, led by Project Management Institute, to Support The Economist Davos Panel17.1.2019 18:00Tiedote

The Brightline™ Initiative, a coalition dedicated to helping executives bridge the gap between strategy design and delivery, along with Project Management Institute is hosting The Economist Events panel discussion entitled “Humans 2.0: Designing and Implementing a Future Proof Strategy.” In line with Davos’ overarching theme, “Globalization 4.0: Shaping a Global Architecture in the Age of the Fourth Industrial Revolution,” panelists will discuss how business leaders can harness the power of people to adapt and implement corporate strategies and grapple with the effects of disruptive technologies. This topic is of particular interest to PMI, the leading member of Brightline, given how this wave of disruption calls for organizations to rely on successful implementation of new strategies at unprecedented scope and speed to meet market demands. “As a coalition committed to moving from idea to strategy implementation to results, we’re delighted to partner with The Economist Events to bring

MSCI Schedules Investor Conference Call to Review Fourth Quarter and Full Year 2018 Results17.1.2019 17:00Tiedote

MSCI Inc. (NYSE:MSCI), a leading provider of indexes and portfolio construction and risk management tools and services for global investors, today announced it will release its results for the fourth quarter and full year 2018 on Thursday, January 31, 2019. MSCI's senior management will review the fourth quarter and full year 2018 results on Thursday, January 31, 2019 at 11:00 AM Eastern Time. To listen to the live event, visit the events and presentations section of MSCI's Investor Relations homepage, http://ir.msci.com/events.cfm, or dial 1-877-376-9931 conference ID: 3474708 within the United States. International callers dial 1-720-405-2251 conference ID: 3474708. The earnings release and related investor presentation used during the conference call will be made available on MSCI's Investor Relations homepage. An audio recording of the conference call will be available on our Investor Relations website, http://ir.msci.com/events.cfm, beginning approximately two hours after the conc

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme